{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T20:01:15Z","timestamp":1784404875061,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007856","name":"Baylor College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jacbts.2025.101454","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:08:22Z","timestamp":1767920902000},"page":"101454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Selective Estrogen Receptor Degraders Induce Bradycardia by Modulating Nuclear Estrogen Signaling"],"prefix":"10.1016","volume":"11","author":[{"given":"Sandeep","family":"Basu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Nathalie","family":"Rosas Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Max","family":"Narvaez-Paliza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0001-2138","authenticated-orcid":false,"given":"Casie","family":"Curtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Kurella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Urias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"More Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaymin M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Asnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2025.101454_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: Global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"The Breast"},{"issue":"19","key":"10.1016\/j.jacbts.2025.101454_bib2","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.3390\/cancers15194689","article-title":"Estrogen receptor signaling in breast cancer","volume":"15","author":"Miziak","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jacbts.2025.101454_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.apcsb.2019.01.001","article-title":"Estrogen receptor signaling mechanisms","volume":"116","author":"Fuentes","year":"2019","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"19","key":"10.1016\/j.jacbts.2025.101454_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914993","article-title":"GPER: an estrogen receptor key in metastasis and tumoral microenvironments","volume":"24","author":"Tirado-Garibay","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"17","key":"10.1016\/j.jacbts.2025.101454_bib5","doi-asserted-by":"crossref","first-page":"9820","DOI":"10.1016\/S0021-9258(17)39309-2","article-title":"Regulation of epidermal growth factor receptor by estrogen","volume":"260","author":"Mukku","year":"1985","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.jacbts.2025.101454_bib6","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1128\/MCB.24.13.5900-5913.2004","article-title":"BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer","volume":"24","author":"Razandi","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jacbts.2025.101454_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","article-title":"Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment","volume":"186","author":"Patel","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jacbts.2025.101454_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111322","article-title":"Mechanisms of endocrine therapy resistance in breast cancer","volume":"532","author":"Rasha","year":"2021","journal-title":"Mol Cell Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.jacbts.2025.101454_bib9","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S0960-9776(19)31118-X","article-title":"Endocrine therapy resistance: new insights","volume":"48","author":"Lei","year":"2019","journal-title":"Breast"},{"issue":"12","key":"10.1016\/j.jacbts.2025.101454_bib10","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.3390\/cancers16122259","article-title":"Resistance to targeted inhibitors of the PI3K\/AKT\/mtor pathway in advanced oestrogen-receptor-positive breast cancer","volume":"16","author":"Browne","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.jacbts.2025.101454_bib11","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.3390\/ijms22157812","article-title":"Oral selective estrogen receptor degraders (SERDs) as a novel breast cancer therapy: present and future from a clinical perspective","volume":"22","author":"Hernando","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jacbts.2025.101454_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1677\/erc.0.0090267","article-title":"Fulvestrant ('Faslodex\u2019)\u2014a new treatment option for patients progressing on prior endocrine therapy","volume":"9","author":"Morris","year":"2002","journal-title":"Endocr Relat Cancer"},{"issue":"5 Suppl 16","key":"10.1016\/j.jacbts.2025.101454_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1053\/j.seminoncol.2003.08.003","article-title":"Fulvestrant: an estrogen receptor antagonist that downregulates the estrogen receptor","volume":"30","author":"Jones","year":"2003","journal-title":"Semin Oncol"},{"issue":"19","key":"10.1016\/j.jacbts.2025.101454_bib14","doi-asserted-by":"crossref","first-page":"OF1","DOI":"10.1158\/1078-0432.CCR-24-1073","article-title":"Elacestrant in ER+, HER2- metastatic breast cancer with ESR1-mutated tumors: subgroup analyses from the phase III EMERALD trial by prior duration of endocrine therapy plus CDK4\/6 inhibitor and in clinical subgroups","volume":"30","author":"Bardia","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"28","key":"10.1016\/j.jacbts.2025.101454_bib15","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1200\/JCO.22.00338","article-title":"Elacestrant (oral selective estrogen receptor degrader) versus standard endocrine therapy for estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: results from the randomized phase III EMERALD Trial","volume":"40","author":"Bidard","year":"2022","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.jacbts.2025.101454_bib16","doi-asserted-by":"crossref","first-page":"11841","DOI":"10.1021\/acs.jmedchem.1c00847","article-title":"GDC-9545 (Giredestrant): a potent and orally bioavailable selective estrogen receptor antagonist and degrader with an exceptional preclinical profile for ER+ breast cancer","volume":"64","author":"Liang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.jacbts.2025.101454_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102825","article-title":"Oral SERDs changing the scenery in hormone receptor\u2013positive breast cancer, a comprehensive review","volume":"130","author":"Gheysen","year":"2024","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10.1016\/j.jacbts.2025.101454_bib18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1158\/1078-0432.CCR-23-1796","article-title":"Phase Ia\/b study of giredestrant \u00b1 palbociclib and \u00b1 luteinizing hormone-releasing hormone agonists in estrogen receptor-positive, HER2-negative, locally advanced\/metastatic breast cancer","volume":"30","author":"Jhaveri","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.jacbts.2025.101454_bib19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.annonc.2024.04.012","article-title":"A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results","volume":"35","author":"Hamilton","year":"2024","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.jacbts.2025.101454_bib20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41574-023-00822-7","article-title":"The G protein-coupled oestrogen receptor GPER in health and disease: an update","volume":"19","author":"Prossnitz","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jacbts.2025.101454_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mce.2016.05.004","article-title":"Estrogen receptor profiling and activity in cardiac myocytes","volume":"431","author":"Pugach","year":"2016","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"10.1016\/j.jacbts.2025.101454_bib22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/CIRCRESAHA.110.236687","article-title":"Estrogen signaling and cardiovascular disease","volume":"109","author":"Murphy","year":"2011","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.jacbts.2025.101454_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007069","article-title":"G protein-coupled estrogen receptor regulates embryonic heart rate in zebrafish","volume":"13","author":"Romano","year":"2017","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.jacbts.2025.101454_bib24","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/toxsci\/kfm107","article-title":"The environmental estrogen, nonylphenol, activates the constitutive androstane receptor","volume":"98","author":"Hernandez","year":"2007","journal-title":"Toxicol Sci"},{"issue":"5","key":"10.1016\/j.jacbts.2025.101454_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10565-020-09516-6","article-title":"Estrogen receptor alpha (ER\u03b1)-mediated coregulator binding and gene expression discriminates the toxic ER\u03b1 agonist diethylstilbestrol (DES) from the endogenous ER\u03b1 agonist 17\u03b2-estradiol (E2)","volume":"36","author":"Adam","year":"2020","journal-title":"Cell Biol Toxicol"},{"issue":"6","key":"10.1016\/j.jacbts.2025.101454_bib26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nchembio.168","article-title":"In vivo effects of a GPR30 antagonist","volume":"5","author":"Dennis","year":"2009","journal-title":"Nat Chem Biol"},{"issue":"5715","key":"10.1016\/j.jacbts.2025.101454_bib27","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1126\/science.1106943","article-title":"A transmembrane intracellular estrogen receptor mediates rapid cell signaling","volume":"307","author":"Revankar","year":"2005","journal-title":"Science"},{"issue":"32","key":"10.1016\/j.jacbts.2025.101454_bib28","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1200\/JCO.2015.61.5831","article-title":"Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: overall survival analysis from the phase II FIRST Study","volume":"33","author":"Ellis","year":"2015","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jacbts.2025.101454_bib29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12282-023-01443-8","article-title":"Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2)","volume":"30","author":"Tamura","year":"2023","journal-title":"Breast Cancer"},{"issue":"5","key":"10.1016\/j.jacbts.2025.101454_bib30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.tcm.2020.04.011","article-title":"The role of the autonomic nervous system in cardiac arrhythmias: the neuro-cardiac axis, more foe than friend?","volume":"31","author":"Manolis","year":"2021","journal-title":"Trends Cardiovasc Med"},{"issue":"8","key":"10.1016\/j.jacbts.2025.101454_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005443","article-title":"Cancer treatment-induced arrhythmias: focus on chemotherapy and targeted therapies","volume":"10","author":"Buza","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"10.1016\/j.jacbts.2025.101454_bib32","first-page":"13","article-title":"Modeling human cardiac arrhythmias: insights from zebrafish","volume":"9","author":"Gauvrit","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"issue":"3","key":"10.1016\/j.jacbts.2025.101454_bib33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.RES.0000258019.74591.b3","article-title":"Molecular pathway for the localized formation of the sinoatrial node","volume":"100","author":"Mommersteeg","year":"2007","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.jacbts.2025.101454_bib34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ydbio.2008.12.028","article-title":"Shox2 is essential for the differentiation of cardiac pacemaker cells by repressing Nkx2-5","volume":"327","author":"Espinoza-Lewis","year":"2009","journal-title":"Dev Biol"},{"issue":"10","key":"10.1016\/j.jacbts.2025.101454_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047644","article-title":"Identification and functional characterization of cardiac pacemaker cells in zebrafish","volume":"7","author":"Tessadori","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jacbts.2025.101454_bib36","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1210\/en.2008-0269","article-title":"G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol","volume":"149","author":"Otto","year":"2008","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.jacbts.2025.101454_bib37","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1158\/0008-5472.CAN-21-2576","article-title":"Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res"},{"issue":"663","key":"10.1016\/j.jacbts.2025.101454_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo5959","article-title":"Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer","volume":"14","author":"Liang","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacbts.2025.101454_bib39","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15298","article-title":"Heart rate variability as a function of menopausal status, menstrual cycle phase, and estradiol level","volume":"10","author":"Ramesh","year":"2022","journal-title":"Physiol Rep"},{"key":"10.1016\/j.jacbts.2025.101454_bib40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1113\/expphysiol.2012.069377","article-title":"Bradycardic effects mediated by activation of G protein-coupled estrogen receptor in rat nucleus ambiguus","volume":"98","author":"Brailoiu","year":"2013","journal-title":"Exp Physiol"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X25004073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X25004073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T17:06:15Z","timestamp":1772298375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X25004073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2452302X25004073"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2025.101454","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective Estrogen Receptor Degraders Induce Bradycardia by Modulating Nuclear Estrogen Signaling","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2025.101454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101454"}}